Skip to content
drillr.ai
Sign up

NAUT

Nautilus Biotechnology, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.90
−1.70%
Ask drillr

  • Jul 28, 2026, 00:00 UTC

    Nautilus Biotechnology reported Q2 2026 financial results with total revenue of $0.2 million and a net loss of $14.5 million.